GSK plc

詳細情報 GSK plc 企業名

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.

GSK plcの企業情報



企業コードGSK

会社名GSK plc

上場日May 22, 1972

最高経営責任者「CEO」Ms. Deborah Waterhouse

従業員数68629

証券種類Ordinary Share

決算期末May 22

本社所在地980 Great West Road

都市BRENTFORD

証券取引所London Stock Exchange

国United Kingdom

郵便番号TW8 9GS

電話番号442080475000

ウェブサイトhttps://www.gsk.com/

企業コードGSK

上場日May 22, 1972

最高経営責任者「CEO」Ms. Deborah Waterhouse

GSK plcの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Hal V. Barron, M.D.

Non-Executive Director

658.41K

+0.49%

Ms. Shobie Ramakrishnan

Chief Digital and Technology Officer

484.59K

+0.08%

Mr. Charles A. (Charlie) Bancroft

Senior Independent Non-Executive Director

38.91K

+0.88%

Ms. Elizabeth McKee (Liz) Anderson

Independent Non-Executive Director

3.00K

+0.87%

Dr. Jeannie Lee

Independent Non-Executive Director and Scientific & Medical Expert

1.58K

+0.83%

Dr. Harry C. (Hal) Dietz

Independent Non-Executive Director, Scientific and Medical Expert

--

Mr. James Ford

Senior Vice President, Group General Counsel, Legal and Compliance

--

Ms. Sally Jackson

Senior Vice President - Global Communications and CEO Office

--

Dr. Tony Wood, Ph.D.

Chief Scientific Officer

--

Ms. Julie Brown

Chief Financial Officer, Executive Director

--

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. Hal V. Barron, M.D.

Non-Executive Director

658.41K

+0.49%

Ms. Shobie Ramakrishnan

Chief Digital and Technology Officer

484.59K

+0.08%

Mr. Charles A. (Charlie) Bancroft

Senior Independent Non-Executive Director

38.91K

+0.88%

Ms. Elizabeth McKee (Liz) Anderson

Independent Non-Executive Director

3.00K

+0.87%

Dr. Jeannie Lee

Independent Non-Executive Director and Scientific & Medical Expert

1.58K

+0.83%

Dr. Harry C. (Hal) Dietz

Independent Non-Executive Director, Scientific and Medical Expert

--

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

データなし

地域別USD

会社名

収益

比率

US

5.49B

51.53%

Rest of world

2.71B

25.44%

Europe

2.45B

23.03%

事業別

地域別

データなし

株主

更新時刻: Sun, Aug 17

株主統計

種類

株主統計

比率

Dodge & Cox

3.88%

Fidelity Management & Research Company LLC

2.54%

Fisher Investments

1.54%

PRIMECAP Management Company

1.37%

JTC Employer Solutions Trusteee Ltd

0.72%

他の

89.96%

株主統計

比率

Dodge & Cox

3.88%

Fidelity Management & Research Company LLC

2.54%

Fisher Investments

1.54%

PRIMECAP Management Company

1.37%

JTC Employer Solutions Trusteee Ltd

0.72%

他の

89.96%

種類

株主統計

比率

Investment Advisor

9.67%

Investment Advisor/Hedge Fund

7.37%

Research Firm

1.05%

Hedge Fund

0.82%

Bank and Trust

0.11%

Individual Investor

0.06%

Pension Fund

0.06%

Insurance Company

0.05%

Family Office

0.03%

他の

80.78%

機関投資家保有株



更新時刻: Wed, Oct 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q3

1447

387.77M

19.07%

-8.51M

2025Q2

1478

378.08M

18.54%

+5.70M

2025Q1

1494

378.46M

18.50%

+5.08M

2024Q4

1481

355.06M

17.14%

+27.38M

2024Q3

1472

319.97M

15.44%

-30.07M

2024Q2

1585

322.06M

15.54%

-29.11M

2024Q1

1617

318.91M

15.39%

-23.52M

2023Q4

1614

299.81M

14.57%

-35.71M

2023Q3

1570

293.92M

14.35%

-37.46M

2023Q2

1545

286.58M

13.99%

-41.88M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

Dodge & Cox

78.76M

3.87%

+106.04K

+0.13%

Jun 30, 2025

Fidelity Management & Research Company LLC

51.48M

2.53%

+872.19K

+1.72%

Jun 30, 2025

Fisher Investments

31.34M

1.54%

+1.31M

+4.35%

Jun 30, 2025

PRIMECAP Management Company

27.73M

1.36%

+2.02M

+7.85%

Jun 30, 2025

JTC Employer Solutions Trusteee Ltd

15.00M

0.74%

-262.98K

-1.72%

Jun 30, 2025

Fidelity Institutional Asset Management

9.53M

0.47%

+10.84K

+0.11%

Jun 30, 2025

T. Rowe Price International Ltd

8.05M

0.4%

+324.11K

+4.20%

Jun 30, 2025

RBC Capital Markets Wealth Management

6.99M

0.34%

+740.61K

+11.84%

Jun 30, 2025

State Street Investment Management (US)

6.71M

0.33%

-258.77K

-3.71%

Jun 30, 2025

Goldman Sachs Asset Management, L.P.

6.12M

0.3%

-2.36M

-27.84%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 20.79B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Feb 05, 2025

GSK.NB Approximate interim Cash Dividend of gross USD 0.400652 paid on Apr 10, 2025 going ex on Feb 21, 2025

Feb 21, 2025

Apr 10, 2025

Feb 21, 2025

Oct 30, 2024

GSK.NB Final Cash Dividend of gross USD 0.376892 paid on Jan 09, 2025 going ex on Nov 15, 2024

Nov 15, 2024

Jan 09, 2025

Nov 15, 2024

Jul 31, 2024

GSK.NB Interim Cash Dividend of gross USD 0.392813 paid on Oct 10, 2024 going ex on Aug 16, 2024

Aug 16, 2024

Oct 10, 2024

Aug 16, 2024

May 01, 2024

GSK.NB Interim Cash Dividend of gross USD 0.384301 paid on Jul 11, 2024 going ex on May 16, 2024

May 17, 2024

Jul 11, 2024

May 16, 2024

Feb 01, 2024

GSK.NB Interim Cash Dividend of gross USD 0.404885 paid on Apr 11, 2024 going ex on Feb 22, 2024

Feb 23, 2024

Apr 11, 2024

Feb 22, 2024

Nov 01, 2023

GSK.NB Final Cash Dividend of gross USD 0.356356 paid on Jan 11, 2024 going ex on Nov 16, 2023

Nov 17, 2023

Jan 11, 2024

Nov 16, 2023

Jul 26, 2023

GSK.NB Interim Cash Dividend of gross USD 0.343532 paid on Oct 12, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Oct 12, 2023

Aug 17, 2023

Apr 26, 2023

GSK.NB Interim Cash Dividend of gross USD 0.360944 paid on Jul 13, 2023 going ex on May 18, 2023

May 19, 2023

Jul 13, 2023

May 18, 2023

Feb 01, 2023

GSK.NB Interim Cash Dividend of gross USD 0.341883 paid on Apr 13, 2023 going ex on Feb 23, 2023

Feb 24, 2023

Apr 13, 2023

Feb 23, 2023

Nov 02, 2022

GSK.NB Final Cash Dividend of gross USD 0.334785 paid on Jan 12, 2023 going ex on Nov 17, 2022

Nov 18, 2022

Jan 12, 2023

Nov 17, 2022

詳細を見る

株式分割



日付

種類

比率

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

日付

種類

比率

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

Jun 24, 2022

Merger

5→4

詳細情報 GSK plc 企業名

GSK plcの企業情報

GSK plcの経営陣

収益内訳

株主

機関投資家保有株

株主動向

関連ETF

配当金

株式分割